Jalleh, R.J.Rayner, C.K.Jones, K.L.Horowitz, M.2025-07-142025-07-142022The Lancet Diabetes and Endocrinology, 2022; 10(9):610-6112213-85872213-8595https://hdl.handle.net/2440/145892CommentAbstract unavailable.en© 2025. Elsevier Inc. All rights reserved.Comment; insulin; a dual incretin receptor agonist; type 2 diabetesHumansDiabetes Mellitus, Type 2Gastric Inhibitory PolypeptideHypoglycemic AgentsGlucagon-Like Peptide 1IncretinsDipeptidyl-Peptidase IV InhibitorsGlucagon-Like Peptide-1 ReceptorIsseki nichō (one stone, two birds): a dual incretin receptor agonist for type 2 diabetes.Journal article10.1016/s2213-8587(22)00193-02024-05-06618733Jalleh, R.J. [0000-0003-4969-4771]Rayner, C.K. [0000-0002-5527-256X]Jones, K.L. [0000-0002-1155-5816]Horowitz, M. [0000-0002-0942-0306]